HANSOH PHARMA EXPANDED THEIR PARTNERSHIP WITH BIOTHEUS FOR DEVELOPING EGFR/CMET BISPECIFIC ANTIBODY-DRUG CONJUGATES
On March 14, 2024, Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK), China's leading innovation-driven pharmaceutical company, and Biot...
2024.03.14